204 related articles for article (PubMed ID: 10390425)
1. Protection against methacholine bronchoconstriction to assess relative potency of inhaled beta2-agonist.
Parameswaran KN; Inman MD; Ekholm BP; Morris MM; Summers E; O'Byrne PM; Hargreave FE
Am J Respir Crit Care Med; 1999 Jul; 160(1):354-7. PubMed ID: 10390425
[TBL] [Abstract][Full Text] [Related]
2. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic equivalence of Spiros dry powder inhaler and Ventolin metered dose inhaler. A bioassay using methacholine.
Ahrens RC; Hendeles L; Clarke WR; Dockhorn RJ; Hill MR; Vaughan LM; Lux C; Han SH
Am J Respir Crit Care Med; 1999 Oct; 160(4):1238-43. PubMed ID: 10508813
[TBL] [Abstract][Full Text] [Related]
4. Agreement between two methods for assessing bioequivalence of inhaled salbutamol.
Lavorini F; Geri P; Camiciottoli G; Pistolesi M; Fontana GA
Pulm Pharmacol Ther; 2008; 21(2):380-4. PubMed ID: 17997115
[TBL] [Abstract][Full Text] [Related]
5. Dose-response protective effect of salbutamol on methacholine airway responsiveness using pressurized metered dose inhalers and Turbuhalers.
Wong AG; O'Byrne PM; Lindbladh C; Inman MD; Stâhl E; Hargreave FE
Can Respir J; 1998; 5(2):119-23. PubMed ID: 9707454
[TBL] [Abstract][Full Text] [Related]
6. Salbutamol tolerance to bronchoprotection: course of onset.
Stewart SL; Martin AL; Davis BE; Cockcroft DW
Ann Allergy Asthma Immunol; 2012 Dec; 109(6):454-7. PubMed ID: 23176887
[TBL] [Abstract][Full Text] [Related]
7. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
Haney S; Hancox RJ
Respir Res; 2005 Sep; 6(1):107. PubMed ID: 16168062
[TBL] [Abstract][Full Text] [Related]
8. Proventil HFA provides protection from exercise-induced bronchoconstriction comparable to proventil and ventolin.
Dockhorn RJ; Wagner DE; Burgess GL; Hafner KB; Letourneau K; Colice GL; Klinger NM
Ann Allergy Asthma Immunol; 1997 Jul; 79(1):85-8. PubMed ID: 9236507
[TBL] [Abstract][Full Text] [Related]
9. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
Yates DH; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
[TBL] [Abstract][Full Text] [Related]
11. The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction.
Giannini D; Di Franco A; Bacci E; Dente FL; Taccola M; Vagaggini B; Paggiaro P
Chest; 2000 May; 117(5):1319-23. PubMed ID: 10807817
[TBL] [Abstract][Full Text] [Related]
12. Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine.
Cockcroft DW; Swystun VA; Bhagat R
Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1485-9. PubMed ID: 7582281
[TBL] [Abstract][Full Text] [Related]
13. Reduced dose salbutamol in comparison with standard dosage for symptom relief in asthma.
Yates DH; Peters MJ; Keatings V; Thomas PS; Barnes PJ
Eur Respir J; 1995 Nov; 8(11):1847-51. PubMed ID: 8620950
[TBL] [Abstract][Full Text] [Related]
14. Regular inhaled salbutamol and airway responsiveness to allergen.
Cockcroft DW; McParland CP; Britto SA; Swystun VA; Rutherford BC
Lancet; 1993 Oct; 342(8875):833-7. PubMed ID: 8104272
[TBL] [Abstract][Full Text] [Related]
15. Proventil HFA provides bronchodilation comparable to ventolin over 12 weeks of regular use in asthmatics.
Bleecker ER; Tinkelman DG; Ramsdell J; Ekholm BP; Klinger NM; Colice GL; Slade HB
Chest; 1998 Feb; 113(2):283-9. PubMed ID: 9498940
[TBL] [Abstract][Full Text] [Related]
16. Dose equivalence and bronchoprotective effects of salmeterol and salbutamol in asthma.
Higham MA; Sharara AM; Wilson P; Jenkins RJ; Glendenning GA; Ind PW
Thorax; 1997 Nov; 52(11):975-80. PubMed ID: 9487346
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic equivalence of three metered-dose inhalers containing salbutamol (Albuterol) in protecting against methacholine-induced bronchoconstriction in children with asthma.
Mallol J; Aguirre V; Rhem R; Rodriguez J; Dolovich M
Pediatr Pulmonol; 2001 Dec; 32(6):447-52. PubMed ID: 11747248
[TBL] [Abstract][Full Text] [Related]
18. Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma.
Lumry W; Noveck R; Weinstein S; Barnhart F; Vandermeer A; Murray A; Reisner C
Ann Allergy Asthma Immunol; 2001 Mar; 86(3):297-303. PubMed ID: 11289328
[TBL] [Abstract][Full Text] [Related]
19. Proventil HFA and ventolin have similar safety profiles during regular use.
Tinkelman DG; Bleecker ER; Ramsdell J; Ekholm BP; Klinger NM; Colice GL; Slade HB
Chest; 1998 Feb; 113(2):290-6. PubMed ID: 9498941
[TBL] [Abstract][Full Text] [Related]
20. Effects of long-acting and short-acting beta-agonists on methacholine dose-response curves in asthmatics.
Wong AG; O'Shaughnessy AD; Walker CM; Sears MR
Eur Respir J; 1997 Feb; 10(2):330-6. PubMed ID: 9042628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
